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CD23 is a low-af®nity receptor for immunoglobulin
E and expressed on various hemopoietic cells.
Although human epidermal cultured Langerhans
cells express CD23, the study to identify CD23 on
murine Langerhans cells has so far failed. In this
study, using highly enriched (> 95%) Langerhans
cells from murine epidermis obtained by the panning
method, we investigated whether murine Langerhans
cells express CD23. As the result of a series of experi-
ments using ¯uorescence activated cell sorter analysis
and the polymerase chain reaction method, it was
revealed that CD23 is expressed on cultured
Langerhans cells, but not on freshly isolated
Langerhans cells. Comparison of the DNA sequence
of polymerase chain reaction products of CD23 from
cultured Langerhans cells with that from spleen leu-
kocytes demonstrated that there were the same
sequences between the two polymerase chain reac-
tion products. The expression of CD23 on cultured
Langerhans cells was downregulated when
Langerhans cells were cultured with keratinocyte-
derived cytokines: interleukin-1a, interleukin-18,
macrophage colony-stimulating factor, or granulo-
cyte-macrophage colony-stimulating factor. More-
over, it was shown that murine IgE bound to
cultured Langerhans cells and this binding was par-
tially inhibited when Langerhans cells were cultured
with monoclonal antibody against CD23 (B3B4).
Thus this study revealed murine cultured Langerhans
cells do express CD23 and the discrepancy from pre-
vious reports may be due to the in¯uence of cyto-
kines derived from keratinocytes. Furthermore, the
®nding that murine cultured Langerhans cells bind
IgE through CD23 suggests that CD23 on murine
Langerhans cells may be involved in IgE-mediated
immune responses. Key words: CD23/cytokine/IgE/
Langerhans cells/mouse. J Invest Dermatol 119:130±136,
2002
C
D23/FceRII, a low-af®nity receptor for IgE, is
expressed at increased levels in atopic individuals
(Buckley et al, 1992) and has been associated with
disorders characterized by chronic in¯ammation
(Bonnefoy et al, 1996). The expression of CD23
has been shown in multiple cell types such as lymphocytes,
eosinophils, platelets, monocytes, and keratinocytes (Bonnefoy et al,
1996; Becherel et al, 1997).
Several functional roles of CD23 have been described, including
T cell-dependent IgE production, augmentation of B cell prolif-
eration, enhancement of antigen presentation, and mediation of T
and B cell cognate interactions (Flores-Romo et al, 1993;
Swendeman and Thorley-Lawson, 1987; Kehry and Yamashita,
1989; Morris et al, 1994). Furthermore, recent ®ndings suggest a
novel interaction between CD23 and the a chain of the b2
integrins, CD11b and CD11c, which leads to proin¯ammatory
patterns of monocyte activation (Lecoanet-Henchoz et al, 1995,
1997).
Epidermis, the most super®cial sheet of the skin, constitutes a
heterogeneous cell population such as keratinocytes, Langerhans
cells, melanocytes, and Merkel cells. Keratinocytes that constitute
the major cell population of the epidermis are not only a physical
barrier, but also are able to synthesize, under various stimuli, many
different cytokines such as interleukin (IL)-1a, IL-6, IL-7, IL-10,
IL-18, tumor necrosis factor (TNF)-a, macrophage colony-stimu-
lating factor (M-CSF), and granulocyte-macrophage colony-stimu-
lating factor (GM-CSF) (Matsue et al, 1992), as well as to express
major histocompatibility complex class II antigens upon interferon
(IFN)-g stimulation.
Langerhans cells are bone-marrow derived major histocompat-
ibility complex class II positive antigen-presenting cells (Katz et al,
1979; Tamaki et al, 1979) in the epidermis and constitute only 1±
3% of epidermal cells. They belong to a dendritic cell lineage, and
are crucial for primary and secondary T cell dependent immune
responses. In human epidermis, CD23 has been shown to be
expressed on both cultured keratinocytes (Becherel et al, 1997) and
cultured Langerhans cells (Bieber et al, 1989); however, it is
reported that neither murine cultured keratinocytes nor cultured
Langerhans cells express CD23 (Hertl et al, 1996). Furthermore,
although human freshly isolated Langerhans cells and cultured
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Langerhans cells express high-af®nity receptor for IgE (FceRI)
(Bieber et al, 1992), it is reported that murine cultured Langerhans
cells do not express FceRI (Hayashi et al, 1999).
With regard to Langerhans cells, we hypothesized that the failure
to detect CD23 on murine Langerhans cells may be due to the effect
of keratinocyte-derived cytokines because murine Langerhans cells
were examined in relatively low purity with contaminating
keratinocytes. As murine Langerhans cells of over 95% purity can
be studied in each experiment (Salgado et al, 1999a, b), the CD23
expression on murine Langerhans cells was re-evaluated.
MATERIALS AND METHODS
Mice Female BALB/c mice were purchased from Japan SLC Co.
(Hamamatsu, Japan) and maintained in the Animal Center for
Biomedical Research (Faculty of Medicine, University of Tokyo).
BALB/c mice were used for experiments at the age of 8±12 wk old.
Reagents and cytokines The culture medium used was RPMI 1640
supplemented with 10% heat-inactivated fetal bovine serum (FBS),
100 U penicillin per ml and 100 mg streptomycin per ml. Murine
recombinant IL (rIL)-4, rIL-10, recombinant IFN-g, and recombinant
TNF-a were purchased from R&D Systems (Minneapolis, MN). Murine
rIL-1a, rIL-12, recombinant GM-CSF, and rIL-18 were obtained from
Pepro Tec Ec (London, U.K). Murine recombinant M-CSF was
purchased from Update (New York, NY). Dispase was purchased from
Godo Shusei (Tokyo, Japan) and diluted at a concentration of 20,000 U
per ml in phosphate-buffered saline (PBS) and stocked at ±20°C.
Deoxyribonuclease I (DNase) was purchased from Sigma (St Louis, MO)
and stored at ±20°C. Red blood cell (RBC) lysing buffer was purchased
from Serotec (London, U.K). Puri®ed mouse monoclonal IgE anti-2,4,6-
trinitrophenyl) was purchased from Pharmingen (San Diego, CA).
Antibodies The following monoclonal antibodies (MoAb) directed
against murine antigens and isotype controls were used for
immunostaining. Fluorescein isothiocyanate-conjugated (FITC-) anti-
mouse CD23 (rat IgG2ak, clone B3B4), FITC-anti-mouse CD11a,
FITC-anti-mouse CD11b, FITC-anti-mouse CD11c, FITC-anti-mouse
CD14, FITC-anti-mouse IgE (rat IgG1k), phycoerythrin-conjugated
(PE-) anti-mouse I-Ad (rat IgG2bk), PE-anti-mouse CD23, puri®ed
anti-mouse CD23 (rat IgG2ak, clone B3B4), puri®ed anti-mouse FcgRII
and FcgRIII (rat IgG2bk, clone 2.4G2), FITC-mouse IgG2ak, FITC-rat
IgG1k, FITC-rat IgG2ak, PE-rat IgG2ak and PE-rat IgG2bk, were
purchased from Pharmingen. FITC-goat anti-mouse IgG was obtained
from Cappel (Durham, NC). FITC-anti-hamster IgG (Jackson
Immunoresearch Laboratories, Baltimore, MA) and FITC-hamster IgG
(Cedarlane, Ontario, Canada) were also used. To detect early or late
apoptotic cells, FITC-Annexin V (R&D systems) was used. For
enrichment of Langerhans cells, mouse anti-mouse I-Ad and goat anti-
mouse IgG (Fc) were obtained from Meiji (Tokyo, Japan) and Cappel,
respectively. The exact concentration of each antibody used in this study
was 5 mg per ml.
Preparation of epidermal cell suspensions Epidermal cells
suspensions were prepared by the method established previously with
slight modi®cation (Koyama et al, 1990; Salgado et al, 1999a, b). Brie¯y,
mice were killed by cervical dislocation and shaved with a hair clipper.
Then trunk skin was peeled and subcutaneous tissue was removed. These
skin specimens were incubated with 3000 U per ml dispase in culture
medium for 4 h at 37°C. Thereafter epidermal sheets were peeled gently
with ®ne forceps from the underlying dermis and transferred to 0.025%
DNase in RPMI 1640 containing 5% FBS. After incubation for 20 min
at room temperature, epidermal sheets were vigorously stirred and
epidermal cells suspensions were passed through the nylon ®lter to
remove hair, stratum corneum, and undissociated fragments. Epidermal
cells were harvested, washed twice in PBS containing 1% FBS by
centrifugation and resuspended in culture medium. The number of
epidermal cells was 1 3 107 per mouse and the viability of cells was
always > 95% by trypan blue exclusion.
Enrichment and culture of Langerhans cells Langerhans cell-
enriched epidermal cells suspensions were obtained using a previously
established method (Koyama et al, 1990; Salgado et al, 1999a, b). Brie¯y
epidermal cells suspensions were treated with mouse anti-mouse I-Ad
MoAb diluted 1:600 in RPMI containing 1% FBS for 45 min at 4°C.
Cells were washed twice with RPMI containing 1% FBS by
centrifugation and seeded on to panning dishes (Falcon; Becton
Dickinson, Franklin Lakes, NJ) for 45 min. The panning dishes had
already been coated at room temperature for more than 4 h with goat
anti-mouse IgG (Fc) diluted 1:100 in PBS, and then had been treated
with RPMI containing 1% FBS for 60 min to avoid nonspeci®c
adhesion of cells. Then in order to remove nonadhesion cells such as
keratinocytes and melanocytes, the dishes were washed with PBS
containing 1% FBS. Finally, adherent Langerhans cells were removed by
vigorous pipetting with RPMI containing 1% FBS and enriched
Langerhans cells were resuspended and cultured in 96-well tissue culture
plates in culture medium with or without various cytokines (2 3 105
Langerhans cells per well).
Preparation and culture of spleen leukocytes The spleen was
removed and cell suspensions were prepared by mechanical vigorous
agitation in PBS containing 1% FBS, and undissociated fragments were
removed through the nylon ®lter. Cell suspensions were incubated in
RBC lysing buffer for 10 min at room temperature to lyse spleen
erythrocytes. The remaining spleen leukocytes were washed twice with
PBS containing 1% FBS and resuspended and cultured in culture
medium of 96-well tissue plates (2 3 105 spleen leukocytes per well).
After isolation or after culture for 24 h or 48 h, spleen leukocytes were
washed and resuspended and stained with FITC-MoAb diluted 1:100 in
PBS containing 1% FBS for FACS analysis. For mRNA isolation with
reverse transcription±polymerase chain reaction (reverse transcription±
PCR), spleen leukocytes cultured for 36 h were used.
Flow cytometric analysis After enrichment or after culture for 24 h
or 48 h, cells were stained either with only the ®rst MoAb for 30 min at
4°C or with the ®rst MoAb followed by the second MoAb at 4°C for
30 min. Then, cells were washed twice and resuspended with PBS
containing 1% FBS, and propidium iodide was added to exclude dead
cells. After 10 min, cells were subject to analysis on FACSCalibur
(Becton Dickinson). More than 5000 cells were used in each experiment
and mean ¯uorescence intensity (MFI) for each surface molecule was
analyzed according to CELLQuest Software User's Guide (Becton
Dickinson). Percent inhibition was expressed as a percentage according
to the following formula:
MFI1 ÿMFI2
MFI1
where MFI1 is MFI of Langerhans cells cultured without cytokines and
stained with anti-mouse CD23, and MFI2 is MFI of Langerhans cells
cultured with cytokines and stained with anti-mouse CD23.
mRNA extraction, reverse transcription±PCR, nested PCR, and
analysis of PCR products mRNA was extracted from cultured
Langerhans cells and cultured spleen leukocytes using Quickprep Micro
mRNA Puri®cation Kit (Pharmacia Biotech, Switzerland). About 100 ng
of mRNA was routinely obtained from 5 3 106 cultured Langerhans
cells and cultured spleen leukocytes. mRNA was denatured at 65°C for
10 min and cooled on ice for 2 min. Thereafter using First-Strand
cDNA Synthesis Kit (Pharmacia Biotech), cDNA was synthesized in
reaction mixture containing reverse transcriptase and random
hexadeoxynucleotides at 37°C for 60 min. The synthesized cDNA was
subject to 30 cycles of reverse transcription±PCR using Taq polymerase
(Toyobo, Osaka, Japan) and the primers speci®c for CD23 and G3PDH
with denaturation for 1 min at 94°C, annealing at 55°C for 1.5 min, and
polymerization at 72°C for 2 min. The used primers for CD23 were
purchased from Sawady Technology (Tokyo, Japan) and the sequences
of the primers for CD23 were 5¢-AGAAAGCGTTGCTGCTGTG-
CAAGAC-3¢ (sense primer) and 5¢-TCAAGCCCAGGGATTTG ATG-
TTGAC-3¢ (anti-sense primer) (Hertl et al, 1996); the primers for
G3PDH were purchased from Clontech Laboratories (Palo Alto, CA),
and the sequences of the primers were 5¢-TGAAGGTCGGTGTGAAC-
GGATTTGGC-3¢ (sense primer) and 5¢-CATGTAGGCCATGAGG;
TCCACCAC-3¢ (anti-sense primer). One milliliter of ®rst PCR
products was ampli®ed using nested PCR primers. The used primers for
nested PCR were also obtained from Sawady Technology and the
sequences of the primers were 5¢-GGATCCAGCACAGCAATGTGG-
GCTGGCC-3¢ (nested sense primer) and 5¢-GGATCCCTTAGATC-
CTCCTGGAGTCCGGT-3¢ (nested anti-sense primer). Ampli®cation
was performed under the same conditions as reverse transcription±PCR
except that the annealing temperature was 57°C. The nested PCR
products were analyzed by electrophoresis on 1.5% agarose gels
containing ethidium bromide.
Sequence of DNA In preparation for sequencing, nested PCR
products were puri®ed using QIAquick PCR Puri®cation Kit (Qiagen,
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Chatsworth, CA) and sequenced by dideoxynucleotide termination
method using ABI Prism BigDye Terminator Cycle Sequencing
Reaction Kit (Applied Biosystems, Foster, CA). Brie¯y, puri®ed nested
PCR products were further ampli®ed with AmpliTaq DNA Polymerase,
FS (Applied Biosystems) using nested sense primer or nested anti-sense
primer. Extension products were puri®ed by ethanol precipitation
method and electrophoresed on ABI Prism 377 DNA Sequencer
(Applied Biosystems). Finally, sequence was analyzed using ABI Prism
Sequencing Analysis (Applied Biosystems).
Determination of IgE binding on cultured Langerhans cells After
culture without cytokines, Langerhans cells and spleen leukocytes were
harvested and resuspended in PBS containing 1% FBS. Langerhans cells
(1 3 105) or spleen leukocytes (1 3 105) were incubated with mouse
IgE for 50 min at 4°C in PBS containing 1% FBS, washed twice in PBS
containing 1% FBS and then incubated with FITC-anti-mouse IgE for
50 min at 4°C in PBS containing 1% FBS. These cell suspensions were
washed twice in PBS containing 1% FBS and subjected to FACS
analysis. For blocking experiments, Langerhans cells (1 3 105) or spleen
leukocytes (1 3 105) were incubated with puri®ed anti-mouse CD23
(B3B4) for 30 min at 4°C. After washing, the cells were incubated with
murine IgE, followed by FITC-anti-mouse IgE as above.
Statistical analysis Student's t test was used to compare the results.
p < 0.05 was considered to be statistically signi®cant.
RESULTS
Purity of freshly isolated Langerhans cells Freshly enriched
preparations routinely contained > 95% Langerhans cells as
determined by FACS analysis (Fig 1A). Freshly isolated
Langerhans cells were NLDC145+/±, CD14±, CD11a+, CD11b+,
and CD11c+. Cultured Langerhans cells were NLDC145+, CD14±,
CD11a+, CD11b+, and CD11c+. These cells had intracytoplasmic
Birbeck's granule. This is consistent with a previous observation
(Salgado et al, 1999; Tada et al, 2000). The viability of freshly
isolated Langerhans cells and cultured Langerhans cells was also
similar to previous results (Salgado et al, 1999a, b).
Murine cultured Langerhans cells, but not freshly isolated
Langerhans cells, express CD23 In the ®rst set of experiments,
freshly isolated Langerhans cells and spleen leukocytes were
cultured without cytokines. Immediately after isolation and after
culture for 24 h and 48 h, both of these cells were single-stained
with FITC-anti-mouse CD23 or with FITC-rat IgG2a. Spleen
leukocytes were used as positive controls because there are
subpopulations that express CD23 in murine spleen leukocytes
(Hertl et al, 1996). Although CD23 was not detectable in freshly
isolated Langerhans cells, CD23 expression on cultured Langerhans
cells was detectable in a time-dependent manner during culture
(Fig 1B, C). After culture for 24 h and 48 h, a small number of
cultured Langerhans cells (about 1%) was propidium iodide (PI)
negative and annexin V positive, and part of these cells were CD23
positive (data not shown).
As it was possible that the failure to detect CD23 on freshly
isolated Langerhans cells was due to dispase used to obtain
epidermal cell suspensions, the effect of dispase on the expression
of CD23 was examined. For this, freshly prepared spleen leukocytes
were stained with FITC-anti-mouse CD23 after incubation with
3000 U per ml dispase in culture medium for 10 min and
compared with untreated spleen leukocytes. There was no change
as for CD23 expression between these cells (data not shown). Thus,
this study indicates that CD23 is dispase resistant and that freshly
isolated Langerhans cells are virtually negative for CD23 at the
protein level.
CD23 is expressed on murine cultured Langerhans cells but
not keratinocytes Previous work has shown that human
keratinocytes express CD23 (Becherel et al, 1997). As it would
be possible that small numbers of contaminating keratinocytes
existed even in our highly enriched cultured Langerhans cells, we
next investigated whether keratinocytes expressed CD23. After
culture for 48 h, the cells were double-stained with FITC-anti-
mouse CD23 and PE-anti-mouse I-Ad or with FITC-rat IgG2a and
PE rat IgG2b. As shown in Fig 2, CD23 expression was only
detectable on I-Ad-positive cells (i.e., cultured Langerhans cells).
There was a population of cultured Langerhans cells that do not
express CD23. The percentage of CD23-positive cultured
Langerhans cells from three different experiments was 34.7 6 7.9
at 48 h. When Langerhans cell-depleted epidermal cells (i.e.,
keratinocytes) were stained for CD23, it was evident that these cells
do not express CD23 at the protein level (Fig 3).
mRNA for CD23 was detected in murine cultured
Langerhans cells, but not in freshly isolated Langerhans
cells or keratinocytes Murine cultured Langerhans cells and
cultured spleen leukocytes were harvested after culture for 36 h,
and mRNA was extracted and cDNA was ampli®ed and analyzed
Figure 1. Purity and CD23 expression of
Langerhans cells. (A) Purity of freshly isolated
Langerhans cells. Freshly isolated Langerhans cells
were stained with FITC-anti-mouse IgG or
FITC-mouse IgG2a (isotype control of FITC-
anti-mouse IgG) and analyzed by FACSCalibur.
(B) Kinetics of CD23 expression on cultured
Langerhans cells. MFI was measured at 0, 24, and
48 h and expressed as mean 6 SD of three
independent experiments. CD23 expression on
cultured Langerhans cells was signi®cantly
upregulated in a time-dependent manner.
*p < 0.05. (C) FACS analysis of CD23 expression
on cultured Langerhans cells and cultured spleen
leukocytes. After being cultured in culture
medium for 24 h in the absence of exogenous
cytokines, cultured Langerhans cells and spleen
leukocytes were harvested and stained with FITC-
anti-mouse CD23 or FITC-rat IgG2a (isotype
control) for 30 min at 4°C, then washed and
analyzed by FACSCalibur. Upper histogram:
cultured Langerhans cells at 24 h; lower histogram:
cultured spleen leukocytes at 24 h; dotted line,
FITC-rat IgG2a, solid line, FITC-anti-mouse
CD23. Spleen leukocytes were used as positive
controls. The representative experiments are
shown.
132 NAGAOKA ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
by electrophoresis. By reverse transcription±PCR and nested PCR,
the band for CD23 mRNA was detected in cultured Langerhans
cells and cultured spleen leukocytes. In freshly isolated Langerhans
cells, however, the band for CD23 mRNA was not detected.
Moreover, in freshly prepared keratinocytes or cultured
keratinocytes, the band for CD23 mRNA was not detected
either. Figure 4 shows the results of nested PCR.
Sequencing of nested PCR products encoding murine
CD23 In order to determine whether nested PCR products
obtained from cultured Langerhans cells and cultured spleen
leukocytes were really CD23, we sequenced these two nested
PCR products according to Materials and Methods and compared
with the corresponding sequences from complete genomic
sequences of murine CD23 (Richards et al, 1991). Our
sequencing and comparison revealed the identity of nested PCR
products of these cells with CD23 (data not shown).
Modulation of CD23 expression on cultured Langerhans
cells by various cytokines The effect of various cytokines
derived from keratinocytes on the expression of CD23 on
Langerhans cells was examined. When Langerhans cells were
cultured with each cytokine (IL-1a, IL-10, IL-18, TNF-a, M-
CSF, and GM-CSF) at a concentration of 0.1 ng per ml, IL-1a, IL-
18, M-CSF, and GM-CSF, but not IL-10 or TNF-a, signi®cantly
inhibited CD23 expression on cultured Langerhans cells compared
with that of Langerhans cells without exogenous cytokines (Fig 5).
Also, these cytokines could not signi®cantly induce apoptosis of
cultured Langerhans cells (data not shown). When Langerhans cells
were cultured for 24 h in a culture supernatant of keratinocytes,
appreciable inhibition of CD23 expression was observed (about
40%). Although it is reported that membrane CD23 on human
Langerhans cells was upregulated by IL-4 and/or IFN-g (Bieber et
al, 1989), no changes were seen by coculture of murine Langerhans
cells with IL-4 and/or IFN-g (data not shown).
Murine cultured Langerhans cells bind IgE through
CD23 In order to examine whether CD23 on murine cultured
Langerhans cells were able to bind IgE, Langerhans cells cultured
without cytokines for 36 h were successively incubated with mouse
IgE and were stained with FITC-anti-mouse IgE. CD23 expression
on both cultured Langerhans cells and spleen leukocytes were seen
in Fig 6(B). As shown in Fig 6(E), cultured Langerhans cells and
spleen leukocytes clearly bound IgE. Preincubation of cultured
Langerhans cells with puri®ed anti-CD23 (B3B4) partially inhibited
the binding of IgE on cultured Langerhans cells (up to 52.3% at
maximum, Fig (6F). As B3B4 is known to interfere with the
binding of IgE to CD23 on B cells (Rao et al, 1987), these results
indicate that murine cultured Langerhans cells bind IgE through
CD23.
Three IgE-binding structures have been reported in murine
Langerhans cells: FcgRII, FcgRIII, and Mac-2 (Haines et al, 1983).
It is known that the rat MoAb 2.4G2 (anti-mouse FcgRII and
FcgRIII) inhibits the binding of IgE to FcgRII and FcgRIII
(Takizawa et al, 1992) and cell surface Mac-2 can be detached from
cells by lactose treatment (Frigeri and Liu, 1992). Preincubation of
Figure 2. FACS analysis of CD23 and I-Ad
expression on cultured Langerhans cells.
Freshly isolated Langerhans cells were cultured for
48 h in culture medium without exogenous
cytokines. Cultured Langerhans cells were
harvested, and double-stained with FITC-anti-
mouse CD23 and PE-anti-mouse I-Ad, or with
FITC-rat IgG2a and PE-rat IgG2b (isotype
controls), then washed and analyzed by
FACSCalibur. The representative data are shown.
Figure 3. FACS analysis of CD23 expression
on Langerhans cells and Langerhans cell-
depleted epidermal cells. Immediately after
preparation or after culture in the absence of
exogenous cytokines, Langerhans cells and
Langerhans cell-depleted epidermal cells were
harvested and stained with FITC-anti-mouse
CD23 or FITC-rat IgG2a (isotype control) for
30 min at 4°C, then washed and analyzed by
FACSCalibur. Upper histogram: Langerhans cells;
lower histogram: Langerhans cell-depleted epidermal
cells; dotted line, FITC-rat IgG2a, solid line,
FITC-anti-mouse CD23. The representative
experiments are shown.
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cultured Langerhans cells with 2.4G2, lactose, and B3B4
completely inhibited the binding of IgE on cultured Langerhans
cells (Fig 6G). When we incubated cultured Langerhans cells with
2.4G2 or lactose, each inhibited the binding of IgE on cultured
Langerhans cells to 30.0% or 27.9%, respectively.
DISCUSSION
We have examined whether CD23 was expressed on murine
Langerhans cells, and if so, whether Langerhans cells could bind IgE
through CD23 molecule. In this study, it has been demonstrated
that: (i) cultured Langerhans cells, but not freshly isolated
Langerhans cells, express CD23; (ii) neither freshly isolated
keratinocytes nor cultured keratinocytes express CD23; (iii)
cultured Langerhans cells may be composed of a heterogeneous
population in terms of the expression of CD23; (iv) cytokines
derived from keratinocytes, such as IL-1a, IL-18, M-CSF, and
GM-CSF, inhibit CD23 expression on cultured Langerhans cells;
(v) murine IgE binds to CD23 on murine cultured Langerhans
cells; and (vi) this binding is inhibited by the addition of anti-CD23
MoAb (B3B4) in culture medium.
Previous study failed to detect CD23 on murine Langerhans
cells. Hertl et al (1996) reported that neither freshly isolated
Langerhans cells nor cultured Langerhans cells expressed CD23;
however, our data clearly showed the expression of CD23 on
cultured Langerhans cells. One possible explanation for this
discrepancy is due to contaminating keratinocyte-derived cytokines
in culture. It is known that murine keratinocytes are the major
source of cytokines in the epidermis and they secrete various
cytokines such as IL-1a, IL-6, IL-7, IL-10, IL-18, TNF-a, M-
CSF, and GM-CSF (Matsue et al, 1992). As revealed in this study,
various keratinocyte-derived cytokines suppressed CD23 expres-
sion on cultured Langerhans cells. In this series of experiments,
Langerhans cells of > 95% purity were used, which minimized the
effect of contaminating keratinocytes. It would also be possible that
freshly isolated Langerhans cells did not express CD23 because
Langerhans cells resided among keratinocytes just before puri®ca-
tion, thus keratinocyte-derived cytokines affected the expression of
CD23 on freshly isolated Langerhans cells.
During culture, Langerhans cells undergo various morphologic,
functional, phenotypic changes. For example, morphologically,
they increase in size, increase the number of the dendrites, and lose
Birbeck granules. Functionally, they lose the capacity of processing
naive peptides, but they activate allogeneic T cells more strongly
than freshly isolated Langerhans cells. Phenotypically, they
upregulate the expression of major histocompatibility complex
class II antigens, ICAM-1, CD40, B7-1, and B7-2. In contrast, E-
cadherin on cultured Langerhans cells is downregulated. Cultured
Langerhans cells that exhibit these series of changes are similar to
migrating Langerhans cells to draining lymph nodes in vivo where
they present antigens to T cells (Schuler et al, 1985; Lappin et al,
1996; Schwarzenberger and Udey, 1996; Salgado et al, 1999a, b).
Thus it is possible that CD23 expression is another phenotypical
change seen in migrating Langerhans cells.
Various functions have already been ascribed to CD23, including
inhibition of apoptosis of germinal center cells, inhibition of IgE
production, maturation of early thymocyte, B cell growth, and
presentation of IgE immune complexes to T cells (Swendeman and
Thorley-Lawson, 1987; Kehry and Yamashita, 1989; Mossalayi et
al, 1990; Bonnefoy et al, 1993; Cho et al, 1997); in this study we
have shown that murine cultured Langerhans cells can bind IgE
through CD23 expressed on cultured Langerhans cells, which is
consistent with that observed in human cultured Langerhans cells
after culture with IL-4 and IFN-g (Bieber et al, 1989). Thus it
would be possible that CD23 on Langerhans cells functions as a
ligand for the IgE immune complex and enhances presentation of
antigens to T cells as already reported in B cells (Kehry and
Yamashita, 1989). As professional antigen presentation cells,
antigen uptake, processing, and presentation are the main functions
of Langerhans cells. In human Langerhans cells, it is reported that
Langerhans cells use FceRI and IgE for antigen internalization
leading to subsequent ef®cient presentation and antigen focusing
(Bieber et al, 1996). We assume similar mechanisms are operating
between CD23 and IgE. This study is under investigation in our
laboratory.
In humans two types of CD23, termed FceRIIa and FceRIIb,
are known according to the differences of cytoplasmic amino acid
sequences in the N terminus (Yokota et al, 1988). The former is
constitutively expressed on B cells and B cell lines, and is further
upregulated by IL-4. The latter exists on various types of cells, such
as monocytes and macrophages, and IL-4 is de®nitely required for
its signi®cant expression. These two molecules are functionally
different: FceRIIa is involved in FceRII-mediated endocytosis,
whereas FceRIIb is associated with IgE-mediated phagocytosis
(Yokota et al, 1992). Although many investigators insisted that
murine CD23 consists of a single isoform (Conrad et al, 1993),
some reports suggest the existence of murine FceRIIb (Richards et
al, 1991). So far, in the murine system two distinct chemical species
have not been identi®ed. The species of CD23 expressed on
cultured Langerhans cells needs further investigation.
It is interesting that a subpopulation of cultured Langerhans cells
expressed CD23. Actually some authors insisted that Langerhans
cells may consist of two functionally different populations. For
example, Furue and Katz (1989) reported that cultured Langerhans
cells may consist of a heterogeneous population in terms of
Figure 4. Results of nested PCR analysis. Freshly isolated
Langerhans cells and spleen leukocytes were cultured in culture medium
for 36 h without exogenous cytokines. mRNA was extracted
immediately after culturing for 36 h, and converted into cDNA. PCR
was run using primers speci®c for the indicated genes. One microliter of
®rst PCR products were subjected to nested PCR using nested sense and
anti-sense primers. Lane 1, cultured spleen leukocytes; lane 2, cultured
Langerhans cells; lane 3, freshly isolated Langerhans cells; lane 4, freshly
prepared keratinocytes; lane 5, cultured (24 h) keratinocytes; lane 6,
cultured (48 h) keratinocytes.
Figure 5. Downregulation of CD23 expression on cultured
Langerhans cells by various cytokines. After being cultured in the
culture medium for 24 h in the presence or absence of keratinocyte-
derived cytokines (0.1 ng per ml), cells were harvested and stained with
FITC-anti-mouse CD23 or FITC-rat IgG2a (isotype control) for 30 min
at 4°C, then analyzed by FACSCalibur. MFI was measured and percent
modulation was calculated and expressed as mean 6 SD of three
independent experiments according to the formula in Materials and
Methods. *Signi®cant compared with the control (p < 0.05).
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sensitivity to dexamethasone, and that dexamethasone may
completely abolish the expression of Ia antigens on a subpopulation
of cultured Langerhans cells or may be cytolytic to this sensitive
population. The experiments by Schwarzenberger and Udey (1996)
showed that cultured Langerhans cells may be divided into two
subpopulations in terms of E-cadherin expression after application
of contact allergens. Our results clearly showed that cultured
Langerhans cells may be divided into two subpopulations in terms
of CD23 expression during culture. With regard to subpopulations
of Langerhans cells, Torresani et al (1991) already reported that
human freshly isolated Langerhans cells are composed of CD23-
positive Langerhans cells (31.2%) and CD23-negative Langerhans
cells (68.8%) by immunoelectron microscopic investigation, which
is in accord with our results of murine cultured Langerhans cells. It
would be possible that these subpopulations have distinct functions
in terms of antigen presentation. This awaits further investigation.
Thus, this study revealed that murine Langerhans cells express
CD23 during culture, and the failure to detect CD23 on murine
Figure 6. FACS analysis of IgE binding on
cultured Langerhans cells and cultured spleen
leukocytes. Freshly isolated Langerhans cells and
spleen leukocytes were cultured for 36 h in
culture medium, then cells were washed and
stained with FITC-MoAb and analyzed as described
in Materials and Methods. The representative
histograms are shown. Cells stained with: (A)
FITC-rat IgG2a; (B) FITC-anti-mouse CD23; (C)
FITC-rat IgG1; (D) FITC-anti-mouse IgE; (E)
mouse IgE followed by FITC-anti-mouse IgE. (F)
Cells incubated with puri®ed anti-mouse CD23
(B3B4) and stained with mouse IgE followed by
FITC-anti-mouse IgE. (G) Cells incubated with
lactose, B3B4, 2.4G2, and stained with mouse IgE
and followed by FITC-anti-mouse IgE.
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Langerhans cells may be due to contaminating keratinocyte-derived
cytokines. Furthermore, the ®nding that murine cultured
Langerhans cells bind IgE through CD23 suggests that CD23 on
murine cultured Langerhans cells may be involved in IgE-mediated
immune responses.
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